GCR USA - 07 April 2020
Two rival providers of erectile dysfunction treatments have allocated the market for their services through an anticompetitive licensing settlement and baseless patent infringement claims, a medical clinic has alleged.
GCR USA - 06 April 2020
The procompetitive benefits of coordination between medical equipment manufacturers to produce more protective equipment for first responders fighting the covid-19 pandemic outweighs any harm, the Department of Justice has said.
GCR USA - 06 April 2020
A group of senators from agriculture-focused states have called for the Department of Justice to investigate potential anticompetitive conduct in the cattle industry.
GCR USA - 03 April 2020
Robin Adelstein has been named head of the Norton Rose Fulbright global competition practice, while litigator Nicholas Boyle has moved from the Williams & Connolly partnership to the Latham & Watkins partnership.
GCR USA - 02 April 2020
Altria agreed to stop competing with rival electronic cigarette manufacturer JUUL in exchange for a 35% stake in the company, the Federal Trade Commission has alleged in a bid to unwind the deal.
GCR USA - 01 April 2020
A federal judge in Delaware has denied auto emissions cleaning technology company Ingevity’s bid to dismiss chemical company BASF’s claims of anticompetitive patent licensing practices.
GCR USA - 31 March 2020
A ventilator manufacturer’s 2012 purchase of a rival start-up contracted to supply the US government’s emergency reserves has some antitrust observers questioning if the Federal Trade Commission missed a “killer acquisition”.
GCR USA - 30 March 2020
Amazon has said that its recent prioritisation of critical products during the coronavirus pandemic resulted in an “unintended variation” to its algorithm, causing certain Amazon product offerings to be featured over those from third-party sellers.
GCR USA - 27 March 2020
The Department of Justice’s antitrust division has required divestitures in three markets to resolve its concerns about defence contracting giant United Technologies Corporation’s purchase of rival Raytheon.
GCR USA - 26 March 2020
Gilead Sciences has asked the US Food and Drug Administration to rescind an orphan drug designation for its experimental covid-19 treatment just days after the agency granted the status.
Data courtesy of FTC.gov